Cargando…

Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition

Melanoma is the most aggressive form of skin cancer, with fast progression and early dissemination mediated by the melanoma inhibitory activity (MIA) protein. Here, we discovered that dimerization of MIA is required for functional activity through mutagenesis of MIA which showed the correlation betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Jennifer, Riechers, Alexander, Stoll, Raphael, Amann, Thomas, Fink, Florian, Spruss, Thilo, Gronwald, Wolfram, König, Burkhard, Hellerbrand, Claus, Bosserhoff, Anja Katrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362532/ https://www.ncbi.nlm.nih.gov/pubmed/22666418 http://dx.doi.org/10.1371/journal.pone.0037941

Ejemplares similares

Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma
por: Massoumi, Ramin, et al.
Publicado: (2009)

Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
por: El Fitori, Jamael, et al.
Publicado: (2005)

Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo
por: Guba, M, et al.
Publicado: (2000)

Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma
por: Linck-Paulus, Lisa, et al.
Publicado: (2020)

Small Molecules Antagonise the MIA-Fibronectin Interaction in Malignant Melanoma
por: Yip, King Tuo, et al.
Publicado: (2016)

MIA/CD-RAP Regulates MMP13 and Is a Potential New Disease-Modifying Target for Osteoarthritis Therapy
por: Staebler, Sebastian, et al.
Publicado: (2023)

Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells
por: Koch, Andreas, et al.
Publicado: (2015)

YBX1 Is a Modulator of MIA/CD-RAP-Dependent Chondrogenesis
por: Schmid, Rainer, et al.
Publicado: (2013)

Xanthohumol, a Prenylated Chalcone Derived from Hops, Inhibits Growth and Metastasis of Melanoma Cells
por: Seitz, Tatjana, et al.
Publicado: (2021)

A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinoma
por: Sasahira, Tomonori, et al.
Publicado: (2016)

Storkhead box 2 and melanoma inhibitory activity promote oral squamous cell carcinoma progression
por: Sasahira, Tomonori, et al.
Publicado: (2016)

Cold Atmospheric Plasma Changes the Amino Acid Composition of Solutions and Influences the Anti-Tumor Effect on Melanoma Cells
por: Arndt, Stephanie, et al.
Publicado: (2021)

C-Jun drives melanoma progression in PTEN wild type melanoma cells
por: Kappelmann-Fenzl, Melanie, et al.
Publicado: (2019)

Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood
por: Vries, T J de, et al.
Publicado: (1999)

Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche
por: Seitz, Tatjana, et al.
Publicado: (2022)

The Delta Subunit of Rod-Specific Photoreceptor cGMP Phosphodiesterase (PDE6D) Contributes to Hepatocellular Carcinoma Progression
por: Dietrich, Peter, et al.
Publicado: (2019)

Melanoma Inhibitory Activity (MIA) Is Able to Induce Vitiligo-Like Depigmentation in an in vivo Mouse Model by Direct Injection in the Tail
por: Bordignon, Matteo, et al.
Publicado: (2020)

Induction of exportin-5 expression during melanoma development supports the cellular behavior of human malignant melanoma cells
por: Ott, Corinna Anna, et al.
Publicado: (2016)

Efficacy of a topical formulation containing MIA (Melanoma Inhibitory Activity) ‐ Inhibitory peptides in a case of recalcitrant vitiligo in combination with UV exposure
por: Hernandez Navarro, Sergi, et al.
Publicado: (2022)

Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model
por: de Jel, Miriam Martha, et al.
Publicado: (2019)

UVB radiation represses CYLD expression in melanocytes
por: Kuphal, Silke, et al.
Publicado: (2017)

Role of Amino Acid Transporter SNAT1/SLC38A1 in Human Melanoma
por: Böhme-Schäfer, Ines, et al.
Publicado: (2022)

HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth
por: Liebig, Janika K., et al.
Publicado: (2020)

Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma()
por: Dietrich, Peter, et al.
Publicado: (2019)

Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinoma
por: Kurihara, M, et al.
Publicado: (2013)

Functional Implication of Netrin Expression in Malignant Melanoma
por: Kaufmann, Simone, et al.
Publicado: (2009)

Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option
por: Dietrich, Peter, et al.
Publicado: (2017)

Enhanced cartilage regeneration in MIA/CD-RAP deficient mice
por: Schmid, R, et al.
Publicado: (2010)

Detection of Cellular Senescence in Human Primary Melanocytes and Malignant Melanoma Cells In Vitro
por: Zimmermann, Tom, et al.
Publicado: (2022)

The neurotrophin Neuritin1 (cpg15) is involved in melanoma migration, attachment independent growth, and vascular mimicry
por: Bosserhoff, Anja Katrin, et al.
Publicado: (2016)

Characterization of the Methylthioadenosine Phosphorylase Polymorphism rs7023954 - Incidence and Effects on Enzymatic Function in Malignant Melanoma
por: Limm, Katharina, et al.
Publicado: (2016)

MAGOH and MAGOHB Knockdown in Melanoma Cells Decreases Nonsense-Mediated Decay Activity and Promotes Apoptosis via Upregulation of GADD45A
por: Soederberg, Agnes, et al.
Publicado: (2022)

Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity
por: Ziani, Linda, et al.
Publicado: (2021)

Melanoma inhibitory activity in Brazilian patients with cutaneous melanoma
por: Odashiro, Macanori, et al.
Publicado: (2015)

Immunosuppressive functions of melanoma cell-derived exosomes in plasma of melanoma patients
por: Whiteside, Theresa L.
Publicado: (2023)

Mechanisms of local immunosuppression in cutaneous melanoma
por: Polak, M E, et al.
Publicado: (2007)

Loss of Chemerin in Rhabdomyosarcoma Cells Polarizes Adjacent Monocytes to an Immunosuppressive Phenotype
por: Sun, Rui, et al.
Publicado: (2022)

Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
por: Schott, Mandy, et al.
Publicado: (2022)

Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA
por: Poncet, Delphine, et al.
Publicado: (2006)

Role of miRNAs in the progression of malignant melanoma
por: Mueller, D W, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rhg2rhs2m0fsndbomp1qnigh5t